FR3033134B1 - Particules d'acide hyaluronique pour des applications cosmetiques ou dermatologiques - Google Patents

Particules d'acide hyaluronique pour des applications cosmetiques ou dermatologiques Download PDF

Info

Publication number
FR3033134B1
FR3033134B1 FR1551711A FR1551711A FR3033134B1 FR 3033134 B1 FR3033134 B1 FR 3033134B1 FR 1551711 A FR1551711 A FR 1551711A FR 1551711 A FR1551711 A FR 1551711A FR 3033134 B1 FR3033134 B1 FR 3033134B1
Authority
FR
France
Prior art keywords
cosmetic
hyaluronic acid
acid particles
dermatological applications
dermatological
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1551711A
Other languages
English (en)
Other versions
FR3033134A1 (fr
Inventor
Kawthar Bouchemal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Original Assignee
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS filed Critical Centre National de la Recherche Scientifique CNRS
Priority to FR1551711A priority Critical patent/FR3033134B1/fr
Priority to EP16710260.7A priority patent/EP3261613A1/fr
Priority to PCT/FR2016/050447 priority patent/WO2016135430A1/fr
Priority to US15/552,318 priority patent/US20180036220A1/en
Publication of FR3033134A1 publication Critical patent/FR3033134A1/fr
Application granted granted Critical
Publication of FR3033134B1 publication Critical patent/FR3033134B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241—Containing particulates characterized by their shape and/or structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/30—Characterized by the absence of a particular group of ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/60—Particulates further characterized by their structure or composition
    • A61K2800/65—Characterized by the composition of the particulate/core
    • A61K2800/654—The particulate/core comprising macromolecular material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Cosmetics (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
FR1551711A 2015-02-27 2015-02-27 Particules d'acide hyaluronique pour des applications cosmetiques ou dermatologiques Expired - Fee Related FR3033134B1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR1551711A FR3033134B1 (fr) 2015-02-27 2015-02-27 Particules d'acide hyaluronique pour des applications cosmetiques ou dermatologiques
EP16710260.7A EP3261613A1 (fr) 2015-02-27 2016-02-26 Particules d'acide hyaluronique pour des applications cosmétiques ou dermatologiques
PCT/FR2016/050447 WO2016135430A1 (fr) 2015-02-27 2016-02-26 Particules d'acide hyaluronique pour des applications cosmétiques ou dermatologiques
US15/552,318 US20180036220A1 (en) 2015-02-27 2016-02-26 Hyaluronic acid particles for cosmetic or dermatological uses

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1551711 2015-02-27
FR1551711A FR3033134B1 (fr) 2015-02-27 2015-02-27 Particules d'acide hyaluronique pour des applications cosmetiques ou dermatologiques

Publications (2)

Publication Number Publication Date
FR3033134A1 FR3033134A1 (fr) 2016-09-02
FR3033134B1 true FR3033134B1 (fr) 2018-05-04

Family

ID=53200132

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1551711A Expired - Fee Related FR3033134B1 (fr) 2015-02-27 2015-02-27 Particules d'acide hyaluronique pour des applications cosmetiques ou dermatologiques

Country Status (4)

Country Link
US (1) US20180036220A1 (fr)
EP (1) EP3261613A1 (fr)
FR (1) FR3033134B1 (fr)
WO (1) WO2016135430A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018024902A1 (fr) * 2016-08-04 2018-02-08 Biokawthar Technologies Utilisations d'acide hyaluronique modifié de manière hydrophobe par des liaisons amide et/ou hydrazide en cosmétique et/ou en dermatologie
CN115003703A (zh) * 2019-12-20 2022-09-02 麻省理工学院 透明质酸衍生物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0725083B1 (fr) * 1994-08-11 2001-11-28 Shiseido Company Limited Acide hyaluronique acetyle a faible poids moleculaire, emollient, et procedes d'obtention et de purification de cet acide
US6673919B2 (en) * 2001-03-30 2004-01-06 Chisso Cororation Chemically modified hyaluronic acid or salts thereof, and a process for producing thereof
JP4323148B2 (ja) * 2002-09-30 2009-09-02 チッソ株式会社 ｎ−アルカノイル化ヒアルロン酸もしくはその塩およびその製造法
JP2007191396A (ja) * 2005-01-07 2007-08-02 Rohto Pharmaceut Co Ltd 皮膚外用剤
US20060251690A1 (en) * 2005-04-01 2006-11-09 Zymes, Llc Skin enrichment using CoQ10 as the delivery system
RU2383341C2 (ru) * 2007-11-29 2010-03-10 Ольга Викторовна Кухарева Способ омоложения кожи
US20100098794A1 (en) * 2008-10-17 2010-04-22 Armand Gerard Topical anti-wrinkle and anti-aging moisturizing cream
JP5420601B2 (ja) 2011-07-25 2014-02-19 株式会社日立ハイテクノロジーズ 荷電粒子装置
FR2989001B1 (fr) * 2012-04-06 2017-07-21 Centre Nat Rech Scient Microparticules et nanoparticules constituees de polysaccharides hydrophobises et d'une alpha-cyclodextrine
TW201343190A (zh) * 2012-04-17 2013-11-01 Bioptik Tech Inc 有關應用於保溼及除皺之皮膚保養組合成份
RU2524663C1 (ru) * 2013-04-26 2014-07-27 Общество с ограниченной ответственностью "ДЖИ-Групп" Комплексное косметическое средство
KR20150015209A (ko) * 2013-07-31 2015-02-10 주식회사 피코테라 저분자 아세틸화 히알루론산의 제조방법 및 이의 용도
CN103505736A (zh) * 2013-09-23 2014-01-15 天津大学 基于改性透明质酸的高分子脂质体及其制备方法

Also Published As

Publication number Publication date
EP3261613A1 (fr) 2018-01-03
WO2016135430A1 (fr) 2016-09-01
FR3033134A1 (fr) 2016-09-02
US20180036220A1 (en) 2018-02-08

Similar Documents

Publication Publication Date Title
MA48994A (fr) Isoquinoléines utilisées en tant qu'inhibiteurs de hpk1
MA55629A (fr) Compositions d'anticorps pour le traitement de tumeurs
MA45192A (fr) Traitement d'association
MA55697A (fr) Molécules d'anticorps pour le traitement du cancer
MA40775A (fr) Dérivé d'acide 4-(4-(4-phényluréido-naphtalén -1-yl) oxy-pyridin-2-yl) amino-benzoïque utilisé en tant qu'inhibiteur de la kinase p38
MA44875A (fr) Compositions pour le traitement de troubles acido-basiques
MA42032A (fr) Acides 3-aryl-4-amido-bicyclo [4,5,0]hydroxamiques en tant qu'inhibiteurs de hdac
FR3011467B1 (fr) Composes et compositions comprenant de tels composes pour la prevention ou le traitement des dyslipidemies
MA49628A (fr) Processus pour la purification de l'acide hyaluronique
MA44737A (fr) Compositions pour le traitement de troubles liés à l'hyperkératose
MA42999A (fr) Polythérapie pour le traitement de malignités
MA42196A (fr) Particules de fumarate de diméthyle et leurs compositions pharmaceutiques
MA43361A (fr) Composition pour le soin et la protection de cultures
MA43570A (fr) Thérapie génique pour traiter l'hypercholestérolémie familiale
FR3037581B1 (fr) Preparation apyrogene contenant des nanoparticules synthetisees par des bacteries magnetotactiques pour des applications medicales ou cosmetiques
FR3013184B1 (fr) Utilisation d'hydroxyapatite pour le traitement de l'esca
MA49841A (fr) Carboxamides utilisées en tant qu'inhibiteurs de protéase spécifique de l'ubiquitine
MA52644A (fr) Compositions pharmaceutiques comprenant de l'acide dgla et leur utilisation
MA43825A (fr) Schémas posologiques pour le traitement d'infections fongiques
FR3023475B1 (fr) Composition cosmetique ou dermatologique solide anhydre a base de particules a liberation d'agent benefique
FR3009956B1 (fr) Composition hydratante sous forme d’emulsion huile-dans-eau ; procede de soin hydratant
FR3015285B1 (fr) Formulation pour le traitement des cheveux
ITUB20153542A1 (it) Composizione cosmetica ad attivita' idratante
FR3033134B1 (fr) Particules d'acide hyaluronique pour des applications cosmetiques ou dermatologiques
FR3007405B1 (fr) Procede de preparation d'une composition comprenant des particules silico/germano-metalliques fonctionnalisees et composition obtenue

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20160902

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

ST Notification of lapse

Effective date: 20221005